Related Experiment Video
Updated: Jul 16, 2026

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
Effector and regulatory T-cell function is differentially regulated by RelB within antigen-presenting cells during
Kelli P A MacDonald1, Rachel D Kuns, Vanessa Rowe
1Bone Marrow Transplantation Laboratory, Queensland Institute of Medical Research, 300 Herston Road, Herston, QLD 4006, Australia.
Graft-versus-host disease (GVHD) severity is reduced by inhibiting RelB in antigen-presenting cells (APCs). This targeted inhibition dissociates effector and regulatory T-cell responses, offering a potential therapeutic strategy for Th1-mediated tissue injury.
Area of Science:
- Immunology
- Cell Biology
- Transplantation Medicine
Background:
- Antigen-presenting cells (APCs) initiate graft-versus-host disease (GVHD), but the specific APC subset and molecular drivers are not fully understood.
- Dendritic cells (DCs) are potent APCs, and the transcription factor RelB is linked to DC maturation and function.
Purpose of the Study:
- To investigate the role of RelB in dendritic cells (DCs) and its involvement in the initiation and progression of GVHD.
- To explore the potential of targeting RelB in APCs as a therapeutic strategy for GVHD.
Main Methods:
- Examined RelB nuclear translocation in host APCs post-irradiation.
- Assessed the impact of transient depletion of CD11c(hi) donor DCs on GVHD severity.
- Utilized RelB knockout (RelB-/-) bone marrow chimeras as recipients and donors to evaluate GVHD dependence on RelB in APCs.
- Analyzed the effect of RelB on donor T cell expansion and function (Th1 and FoxP3+ regulatory T cells).
Main Results:
- RelB nuclear translocation increased in host CD11c(hi) DCs within 4 hours of irradiation.
- Transient depletion of CD11c(hi) donor DCs led to a temporary decrease in GVHD severity.
- GVHD induction and maintenance were critically dependent on RelB in both host and donor APCs.
- RelB in APCs was essential for the expansion of donor Th1 effector cells and alloreactivity, but not for regulatory T cell expansion or function.
Conclusions:
- RelB within APCs plays a critical role in driving GVHD by promoting Th1 effector cell expansion.
- Targeted inhibition of nuclear RelB translocation in APCs could be a promising therapeutic approach to manage GVHD.
- This strategy may allow for the dissociation of effector and regulatory T cell responses, mitigating Th1-mediated tissue injury.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...

